The Clinical importance of microbiological findings in the diagnosis and management of bloodstream infections

Clinical Infectious Diseases

Volumn 48, Issue SUPPL. 4, 2009, Pages

  Seifert, Harald ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; ERYTHROMYCIN; FLUORODEOXYGLUCOSE F 18; GENTAMICIN; HEPARIN; IMIPENEM; PENICILLIN G;

ADULT; ANTIBIOTIC THERAPY; BACTEREMIA; BACTERIAL ENDOCARDITIS; BACTERIAL PNEUMONIA; BLOOD CULTURE; BLOODSTREAM INFECTION; CASE REPORT; CATHETER INFECTION; CATHETER REMOVAL; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; CORONARY ARTERY BYPASS GRAFT; ESCHERICHIA COLI; FEMALE; HEPARINIZATION; HUMAN; HUMAN TISSUE; MALE; MORBIDITY; MORTALITY; PRIORITY JOURNAL; RHODOCOCCUS EQUI; STREPTOCOCCUS ANGINOSUS; STREPTOCOCCUS BOVIS; STREPTOCOCCUS INFECTION; THROMBOPHLEBITIS; THROMBUS; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; VENTILATOR ASSOCIATED PNEUMONIA; ACTINOMYCETALES INFECTION; AGED; ARTICLE; COLON TUMOR; DECUBITUS; DUODENUM ULCER; ESCHERICHIA COLI INFECTION; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; POSITRON EMISSION TOMOGRAPHY;

ACTINOMYCETALES INFECTIONS; AGED; BACTEREMIA; CATHETER-RELATED INFECTIONS; COLONIC NEOPLASMS; DUODENAL ULCER; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; PRESSURE ULCER; RHODOCOCCUS EQUI; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS ANGINOSUS; STREPTOCOCCUS BOVIS;

EID: 65649140523     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/598188     Document Type: Conference Paper

References (43)

1. Bearman GM, Wenzel RP. Bacteremias: a leading cause of death. Arch Med Res 2005; 36:646-59.
2. Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis 2004; 39:309-17.
3. Leibovici L, Shraga I, Drucker M, Konigsberger H, Samra Z, Pitlik SD. The benefit of appropriate empirical antibiotic treatment in patients with bloodstream infection. J Intern Med 1998; 244:379-86.
4. Lodise TP, McKinnon PS, Swiderski L, Rybak MJ. Outcomes analysis of delayed antibiotic treatment for hospital-acquired Staphylococcus aureus bacteremia. Clin Infect Dis 2003; 36:1418-23.
5. Kollef M. Appropriate empirical antibacterial therapy for nosocomial infections: getting it right the first time. Drugs 2003; 63:2157-68.
6. Reimer LG, Wilson ML, Weinstein MP. Update on detection of bacteremia and fungemia. Clin Microbiol Rev 1997; 10:444-65.
7. Munson EL, Diekema DJ, Beekmann SE, Chapin KC, Doern GV. Detection and treatment of bloodstream infection: laboratory reporting and antimicrobial management. J Clin Microbiol 2003; 41:495-7.
8. Cockerill FR III,Wilson JW, Vetter EA, et al. Optimal testing parameters for blood cultures. Clin Infect Dis 2004; 38:1724-30.
9. Lee A, Mirrett S, Reller LB, Weinstein MP. Detection of bloodstream infections in adults: how many blood cultures are needed? J Clin Microbiol 2007; 45:3546-8.
10. Weinstein MP, Towns ML, Quartey SM, et al. The clinical significance of positive blood cultures in the 1990s: a prospective comprehensive evaluation of the microbiology, epidemiology, and outcome of bacteremiaand fungemia in adults. Clin Infect Dis 1997; 24:584-602.
11. Renaud B, Brun-Buisson C. Outcomes of primary and catheter-related bacteremia: a cohort and case-control study in critically ill patients. Am J Respir Crit Care Med 2001; 163:1584-90.
12. Diekema DJ, Beekmann SE, Chapin KC, Morel KA, Munson E, Doern GV. Epidemiology and outcome of nosocomial and community-onset bloodstream infection. J Clin Microbiol 2003; 41:3655-60.
13. Safdar N, Fine JP, Maki DG. Meta-analysis: methods for diagnosing intravascular device-related bloodstream infection. Ann Intern Med 2005; 142:451-66.
14. Mermel LA, Farr BM, Sherertz RJ, et al. Guidelines for the management of intravascular catheter-related infections. J Intraven Nurs 2001; 24: 180-205.
15. Kempf VA, Trebesius K, Autenrieth IB. Fluorescent in situ hybridization allows rapid identification of microorganisms in blood cultures. J Clin Microbiol 2000; 38:830-8.
16. Wellinghausen N,Wirths B, Essig A,Wassill L. Evaluation of theHyplex BloodScreen multiplex PCR-enzyme-linked immunosorbent assay system for direct identification of gram-positive cocci and gram-negative bacilli from positive blood cultures. J Clin Microbiol 2004; 42:3147-52.
17. Shrestha NK, Tuohy MJ, Hall GS, Isada CM, Procop GW. Rapid identification of Staphylococcus aureus and the mecA gene from BacT/ ALERT blood culture bottles by using the LightCycler system. J Clin Microbiol 2002; 40:2659-61.
18. Horstkotte D, Follath F, Gutschik E, et al. Guidelines on prevention, diagnosis and treatment of infective endocarditis executive summary. Task Force on Infective Endocarditis of the European Society of Cardiology. Eur Heart J 2004; 25:267-76.
19. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections. In: Olmsted RN, ed. APIC infection control and applied epidemiology: principles and practice. St. Louis: Mosby, 1996:A1-20.
20. Centers for Disease Control and Prevention. Guidelines for the prevention of intravascular catheter-related infections. MMWR Recomm Rep 2002; 51(RR-10):1-9.
21. Bryan CS. Clinical implications of positive blood cultures. Clin Microbiol Rev 1989; 2:329-53.
22. Fowler VG Jr, Miro JM, Hoen B, et al. Staphylococcus aureus endocarditis: a consequence of medical progress. JAMA 2005; 293:3012-21.
23. Livorsi DJ, Daver NG, Atmar RL, Shelburne SA, White AC Jr, Musher DM. Outcomes of treatment for hematogenous Staphylococcus aureus vertebral osteomyelitis in the MRSA era. J Infect 2008; 57:128-31.
24. Chu VH, Woods CW, Miro JM, et al. Emergence of coagulase-negative staphylococci as a cause of native valve endocarditis. Clin Infect Dis 2008; 46:232-42.
25. Rupp ME, Archer GL. Coagulase-negative staphylococci: pathogens associated with medical progress. Clin Infect Dis 1994; 19:231-43.
26. Bert F, Bariou-Lancelin M, Lambert-Zechovsky N. Clinical significance of bacteremia involving the "Streptococcus milleri" group: 51 cases and review. Clin Infect Dis 1998; 27:385-7.
27. Whiley RA, Beighton D, Winstanley TG, Fraser HY, Hardie JM. Streptococcus intermedius, Streptococcus constellatus, and Streptococcus anginosus (the Streptococcus milleri group): association with different body sites and clinical infections. J Clin Microbiol 1992; 30:243-4.
28. Hoen B. Special issues in the management of infective endocarditis caused by gram-positive cocci. Infect Dis Clin North Am 2002; 16: 437-52, xi.
29. Gold JS, Bayar S, Salem RR. Association of Streptococcus bovis bacteremia with colonic neoplasia and extracolonic malignancy. Arch Surg 2004; 139:760-5.
30. Ferrari A, Botrugno I, Bombelli E, Dominioni T, Cavazzi E, Dionigi
31. P. Colonoscopy is mandatory after Streptococcus bovis endocarditis: a lesson still not learned. Case report. World J Surg Oncol 2008; 6:49.
32. Gonzalez-Juanatey C, Gonzalez-Gay MA, Llorca J, et al. Infective endocarditis due to Streptococcus bovis in a series of nonaddict patients: clinical and morphological characteristics of 20 cases and review of the literature. Can J Cardiol 2003; 19:1139-45.
33. Fernandez Guerrero ML, Goyenechea A, Verdejo C, Roblas RF, de
34. Gorgolas M. Enterococcal endocarditis on native and prosthetic valves: a review of clinical and prognostic factors with emphasis on hospitalacquired infections as a major determinant of outcome. Medicine (Baltimore) 2007; 86:363-77.
35. Maki DG, Agger WA. Enterococcal bacteremia: clinical features, the risk of endocarditis, and management. Medicine (Baltimore) 1988; 67: 248-69.
36. Koransky JR, Stargel MD, Dowell VR Jr. Clostridium septicum bacteremia: its clinical significance. Am J Med 1979; 66:63-6.
37. Cheng AC, Currie BJ. Melioidosis: epidemiology, pathophysiology, and management. Clin Microbiol Rev 2005; 18:383-416.
38. Benenson S, Raveh D, Schlesinger Y, et al. The risk of vascular infection in adult patients with nontyphi Salmonella bacteremia. Am J Med 2001; 110:60-3.
39. Riordan T. Human infection with Fusobacterium necrophorum (necrobacillosis), with a focus on Lemierre's syndrome. Clin Microbiol Rev 2007; 20:622-59.
40. Hossenbux K, Dale BA, Walls AD, Lawrence JR. Streptococcus bovis endocarditis and colonic carcinoma: a neglected association. Br Med J (Clin Res Ed) 1983; 287:21.
41. Klein RS, Recco RA, Catalano MT, Edberg SC, Casey JI, Steigbigel NH. Association of Streptococcus bovis with carcinoma of the colon. N Engl J Med 1977; 297:800-2.
42. Waisberg J, Matheus CdO, Pimenta J. Infectious endocarditis from Streptococcus bovis associated with colonic carcinoma: case report and literature review. Arq Gastroenterol 2002; 39:177-80.
43. MurrayHW, Roberts RB. Streptococcus bovis bacteremia and underlying gastrointestinal disease. Arch Intern Med 1978; 138:1097-9.